Literature DB >> 24763071

Functional disability in Alzheimer disease: a validation study of the Turkish version of the disability assessment for dementia scale.

Mukaddes Tozlu1, Mustafa Cankurtaran1, Burcu Balam Yavuz2, Eylem Sahin Cankurtaran3, Ibrahim Kutluer4, Burcu Manisalı Erkek3, Meltem Halil1, Zekeriya Ulger1, Erdal Cosgun5, Servet Ariogul1.   

Abstract

This study aimed to determine the reliability and validity of the Turkish version of Disability Assessment for Dementia (DAD) scale in the Turkish elderly population with Alzheimer disease (AD). The DAD scale was administered to the primary caregivers of 157 patients (age 77.7 ± 6.8 years) with AD. The Turkish version of the DAD scale showed high internal consistency (Cronbach α = .942), excellent test-retest, and interrater reliability (intraclass correlation coefficient [ICC] = 0.996 and ICC = 0.994, respectively). The DAD scale was significantly correlated with activities of daily living (ADL; Modified Older Americans Research Survey ADL) and instrumental activities of daily living (IADL; Lawton and Brody IADL) scales (r = .89, P < .001 and r = .90, P < .001). Disability Assessment for Dementia had a high negative correlation with the Global Deterioration Scale (GDS; r = -.880, P < .001). Post hoc comparisons with Tukey test showed significant differences in the mean DAD scores in different GDS stages. Construct validity was estimated using total score correlation analyses between the standardized Mini-Mental State Examination (MMSE) and the DAD scale. Results revealed high and significant correlation between MMSE score and DAD scale (r = .812, P < .001). The results of multivariate analysis showed that DAD score was not correlated with gender, education, and age. The DAD total score was affected mostly by GDS, MMSE, and duration of the disease. Turkish version of the DAD scale was found to be a reliable and valid instrument to assess functional disability in Turkish elderly patients with AD. This scale assists caregivers and physicians to decide for proper interventions.
© The Author(s) 2014.

Entities:  

Keywords:  Alzheimer disease; Disability Assessment for Dementia; functional assessment; functional disability

Mesh:

Year:  2014        PMID: 24763071     DOI: 10.1177/0891988714532014

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  4 in total

1.  Validation Study of the Spanish Version of the Disability Assessment for Dementia Scale.

Authors:  Alicia Sánchez-Pérez; Sofía López-Roig; Ana Pampliega Pérez; Paula Peral Gómez; María Ángeles Pastor; Miriam Hurtado Pomares
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.889

2.  Analysis of Risk Factors for Cognitive Dysfunction in Disabled Elderly Patients in Chengdu, China.

Authors:  Xiaoyan Chen; Ying Zhang; Lisha Hou; Yanjiao Shen; Jianqun Li; Birong Dong
Journal:  Med Sci Monit       Date:  2020-07-09

3.  Thyroid Hormone Enhances Neurite Outgrowth in Neuroscreen 1 Cells.

Authors:  Oldham Ce; Wooten Cj; Williams Ab; Dixon S; Lopez D
Journal:  Int J Biomed Investig       Date:  2018-03-30

4.  Instrumental Activities of Daily Living Scales to Detect Cognitive Impairment and Dementia in Low- and Middle-Income Countries: A Systematic Review.

Authors:  Heather Yemm; Dame Louise Robinson; Stella-Maria Paddick; Catherine Dotchin; Michaela Louise Goodson; Alla Narytnyk; Marie Poole; Ríona Mc Ardle
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.